Pharmadrug Inc.
PHRX
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 97.91% | 97.52% | 94.39% | -1,032.89% | -659.92% |
| Total Depreciation and Amortization | -4.50% | 26.57% | 90.16% | 761.97% | 1,500.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -89.95% |
| Total Other Non-Cash Items | -98.80% | -98.21% | -98.08% | 332.11% | 6,717.91% |
| Change in Net Operating Assets | 94.90% | -284.07% | -201.74% | -192.31% | -205.56% |
| Cash from Operations | 92.20% | 80.05% | -12.43% | -139.13% | -106.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -248.28% | -125.29% | -104.58% | -100.08% | -97.69% |
| Cash from Investing | -101.56% | -101.49% | -101.17% | 111.24% | 116.34% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -64.97% | -63.98% | -60.65% | -118.74% | 1,011.72% |
| Cash from Financing | -100.75% | -100.64% | 41.02% | 30.56% | 16.44% |
| Foreign Exchange rate Adjustments | -230.77% | -200.00% | -177.27% | -85.71% | 100.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -100.00% |
| Net Change in Cash | -186.74% | -172.99% | -181.16% | -118.97% | 350.24% |